Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 46,916 | 69,806 | 46,573 | 40,785 | 35,235 |
| Operating Income | -46,916 | -69,806 | -46,573 | -40,785 | -35,235 |
| Other Income | 6,637 | 6,868 | 7,758 | 7,864 | 7,303 |
| Pre-tax Income | -40,279 | -62,938 | -38,815 | -32,921 | -27,932 |
| Income Tax | 243 | 231 | 349 | 221 | 251 |
| Net Income Continuous | -40,522 | -63,169 | -39,164 | -33,142 | -28,183 |
| Net Income | $-40,522 | $-63,169 | $-39,164 | $-33,142 | $-28,183 |
| EPS Basic Total Ops | -0.48 | -0.75 | -0.46 | -0.40 | -0.34 |
| EPS Basic Continuous Ops | -0.48 | -0.75 | -0.47 | -0.40 | -0.34 |
| EPS Diluted Total Ops | -0.48 | -0.75 | -0.46 | -0.40 | -0.34 |
| EPS Diluted Continuous Ops | -0.48 | -0.75 | -0.47 | -0.40 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.75 | -0.47 | -0.40 | N/A |
| EBITDA(a) | $-49,836 | $-73,190 | $-50,814 | $-44,998 | $-38,828 |